Leukocytosis caused by prostaglandin E1 in neonates

Journal of Pediatrics

Volumn 138, Issue 2, 2001, Pages 263-265

  Arav Boger, Ravit ^a   Baggett, Henry C ^a   Spevak, Philip J ^a   Willoughby, Rodney E ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; PROSTAGLANDIN E1; PROSTAGLANDIN E2;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYANOTIC HEART DISEASE; DOSE TIME EFFECT RELATION; HUMAN; IMMUNOMODULATION; LEUKOCYTE COUNT; LEUKOCYTOSIS; NEWBORN; PRIORITY JOURNAL;

EID: 0035134876     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2001.110304     Document Type: Article

References (7)

1. 1 in infants with critical congenital heart disease
2. Cortical hyperostosis: A complication of prolonged prostaglandin infusion in infants awaiting cardiac transplantation
3. 1 attenuates cytotoxic mechanisms of primed neutrophils
4. The CD11/CD18 leukocyte glycoprotein deficiency
5. (15S)-15-Methyl prostaglandinE1-induced neutrophilia in Brown-Norway rats
6. Leukocyte counts in children with sickle cell disease. Comparative values in the steady state, vaso-occlusive crisis, and bacterial infection
7. Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis